Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
475 USD | +1.02% | +6.29% | +16.73% |
06-03 | Vertex Pharmaceuticals Insider Sold Shares Worth $2,033,159, According to a Recent SEC Filing | MT |
05-31 | BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B | |
+83.67% | 9.02B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex's Cystic Fibrosis Combo Gets Extended EU Nod For Treating Children